key: cord-0812685-dwtxyxzc
authors: Abdelhafiz, A.; Munshi, S.; Reza, S.
title: P.185 Safe management of a patient with COVID-19-induced thrombocytopenia for an elective caesarean section
date: 2022-05-31
journal: International Journal of Obstetric Anesthesia
DOI: 10.1016/j.ijoa.2022.103481
sha: fff0e63c7f98afef74fe873b2507db444a7efb2d
doc_id: 812685
cord_uid: dwtxyxzc

nan

tachycardic but oxygen saturations were 100% on air. There were no recent blood results available. A successful single-shot spinal anaesthetic was performed and her baby was delivered in good condition and the operation was uncomplicated. She was discharged home day 2 post CS, but deteriorated day 10 of her COVID-19 illness with worsening hypoxia secondary to COVID-19 pneumonitis. She was admitted to ICU for invasive ventilation and proning. Unfortunately she was not deemed a candidate for extracorporeal membrane oxygenation (ECMO), and after a superimposed bacterial infection, deteriorated precipitously and passed away after three weeks in ICU. Discussion: We carried out regional anaesthesia in this patient after risk-benefit analysis. Despite the potential risks of thrombocytopenia and disseminated intravascular coagulopathy with COVID-19, we felt the benefits of spinal anaesthesia in a patient with malignant hyperthermia, fetal compromise and potential postoperative respiratory decompensation outweighed these risks [1] . Prior handover from the high-risk clinic enabled preparation for total intravenous anaesthesia at short notice. She tolerated the spinal anaesthetic well and was able to spend time with her baby immediately after. This case is important as the management of patients for operative delivery with COVID-19 is becoming more important with increasing prevalence and low number of pregnant patients vaccinated. Introduction: Thrombocytopenia occurs in one-third of patients with COVID-19 infection compared with 7-12% of non-COVID pregnant patients [1] . We describe the anaesthetic management of a patient with COVID-19 undergoing an elective caesarean section presented with moderate thrombocytopenia. Case Report: A 28-year-old nulliparous woman at 39 + 4 weeks of gestation was listed for an elective caesarean section due to breech presentation. Her past medical history included mild anxiety. At 28 weeks the platelet count was 111 × 10 9 /L and 72 × 10 9 /L at term. Preeclampsia had been excluded. Asymptomatic COVID-19 infection was incidentally discovered a week before delivery. The agreed anaesthetic plan was to request platelets to be available as they take 75 minutes to procure. Spinal anaesthetic was planned as per the current COVID-19 guidelines. There were concerns regarding the risk of epidural haematoma due to thrombocytopenia. A pool of platelets was given preoperatively as per the recommendation of the haematologist. The post-transfusion platelet count was 86 × 10 9 /L. Spinal anaesthetic was performed with a 25G Sprotte needle. Hyperbaric bupivacaine 12.5 mg with diamorphine 300 μg was used. It was an uneventful caesarean section with an estimated blood loss of 500 mL. The woman's platelet count 6 hours postoperatively was 87 × 10 9 /L and increased to 96 × 10 9 /L after 2 days. Discussion: Thrombocytopenia during pregnancy affects 5-10% of patients [2] . Aetiologies include gestational/immune thrombocytopenia, preeclampsia, and HELLP (haemolysis, elevated liver enzymes and low platelets) syndrome. Mild thrombocytopenia was recorded in a third of non-pregnant patients with COVID-19. Thrombocytopenia is frequently associated with moderate to severe coronavirus disease. Many observations show that moderate to severe thrombocytopenia can exist in asymptomatic COVID-19. Thrombocytopenia was found in 2 of 14 cases (14%) of COVID-19 patients undergoing neuraxial procedures with the lowest reported platelet count of 81 × 10 9 /L [1] . A platelet count of 70 × 10 9 /L carries a low risk for neuraxial anaesthesia, especially for those at high risk for general anaesthesia [1] . We opted for transfusion of one platelet pool preoperatively considering the borderline platelet count and the progressive course of thrombocytopenia. Appropriate monitoring of the platelet count is essential to enable safe discharge. Good communication between clinical teams and haematologist ensured a positive outcome for our patient and her baby.

Neuraxial procedures in COVID-19 positive parturient: a review of current reports

Thrombocytopenia in pregnancy